Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | IKBKB | O14920 | 2/20 | 0.37 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.36 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.35 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.34 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.34 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.34 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | SREBF2 | Q12772 | 1/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.33 |
| ▸ | GUSB | P08236 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21089489 | 0.99 | TSHR (0.40) | TSHRHSD17B10IKBKBLTB4R2PDCD1 | |
| SCHEMBL21089308 | 0.87 | PDCD1 (0.38) | TSHRLTB4R2PDCD1CD274TRPM8 | |
| SCHEMBL21089444 | 0.86 | PDCD1 (0.37) | PDCD1CD274TRPM8PSMB5APP | |
| SCHEMBL21089306 | 0.86 | PDCD1 (0.37) | PDCD1CD274TRPM8PSMB5APP | |
| SCHEMBL21089439 | 0.83 | PDCD1 (0.39) | PDCD1CD274TRPM8PSMB5APP | |
| SCHEMBL21089293 | 0.83 | PDCD1 (0.42) | PDCD1CD274TRPM8PSMB5APP | |
| SCHEMBL21089508 | 0.82 | PDCD1 (0.33) | TSHRHSD17B10LTB4R2PDCD1CD274 | |
| SCHEMBL21089455 | 0.80 | ABCB1 (0.39) | HSD17B10PDCD1CD274TRPM8ABCB1 | |
| SCHEMBL21089311 | 0.80 | PDCD1 (0.36) | PDCD1CD274TRPM8APPSREBF2 | |
| SCHEMBL21089184 | 0.79 | APP (0.43) | HSD17B10TRPM8ABCB1ABCG2APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569461-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-01-31 | — | — | US | disclosed |
| US-20190181358-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | LAPTO CO., LTD. (KR) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569461-B2 | Organic electroluminescence device and organometallic compound for organic electroluminescence device | CHRM1, L1CAM, CHRM4 | TSHR 2815/4885HSD17B10 4197/4885IKBKB 4763/4885 |
| US-20190181358-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANOMETALLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | CHRM1, L1CAM, CHRM4 | TSHR 2815/4885HSD17B10 4197/4885IKBKB 4763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.